Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Research at Kyorin leads to effective blood glucose-lowering agents

May 6, 1998

Signal awarded SBIR phase II grant for osteoporosis research

May 6, 1998

Hemolink cleared by FDA for phase II testing in chronic anemia

May 6, 1998

Noven and Novartis establish joint venture to promote Vivelle

May 6, 1998

Sanguine funds development of blood substitute

May 6, 1998

Generex completes proof-of-concept trials with oral insulin

May 5, 1998

Harvard Scientific unveils new treatment for female sexual dysfunction

May 5, 1998

New antidiabetic agent in the pipeline at Sumitomi Metal

May 5, 1998

HMG-CoA reductase inhibition upregulates ecNOS expression in vitro

May 5, 1998

BRL-49653 may mediate insulin sensitivity by reducing FFA release from adipocytes

May 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...